What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
Paolo Stanzione mostly deals with Parkinson's disease, Neuroscience, Internal medicine, Central nervous system disease and Degenerative disease.
His Parkinson's disease research focuses on Subthalamic nucleus in particular.
His Neuroscience research includes themes of Glutamate receptor and Deep brain stimulation.
His research integrates issues of Endocrinology and Pathology in his study of Internal medicine.
His Central nervous system disease research is multidisciplinary, relying on both Reflex and Apomorphine.
Paolo Stanzione has included themes like Alzheimer's disease, Somatosensory evoked potential, Dementia and Audiology in his Degenerative disease study.
His most cited work include:
- Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease (642 citations)
- Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. (359 citations)
- Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement. (248 citations)
What are the main themes of his work throughout his whole career to date?
Paolo Stanzione mainly investigates Parkinson's disease, Internal medicine, Neuroscience, Anesthesia and Deep brain stimulation.
Paolo Stanzione has researched Parkinson's disease in several fields, including Dopaminergic, Apomorphine and Neurology.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Cardiology.
His studies in Basal ganglia, Electrophysiology, Dopamine, Stimulation and Transcranial magnetic stimulation are all subfields of Neuroscience research.
Paolo Stanzione interconnects Substantia nigra and Excitatory postsynaptic potential in the investigation of issues within Stimulation.
Subthalamic nucleus and Pedunculopontine nucleus are the primary areas of interest in his Deep brain stimulation study.
He most often published in these fields:
- Parkinson's disease (43.03%)
- Internal medicine (29.10%)
- Neuroscience (27.87%)
What were the highlights of his more recent work (between 2012-2021)?
- Parkinson's disease (43.03%)
- Internal medicine (29.10%)
- Radiology (6.56%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Parkinson's disease, Internal medicine, Radiology, Anesthesia and Disease.
His studies in Parkinson's disease integrate themes in fields like Clinical psychology and Urology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Electroencephalography and Cardiology.
His work in Disease tackles topics such as Dopaminergic which are related to areas like Cerebrospinal fluid and Pathology.
His Levodopa study combines topics in areas such as Hearing loss, Audiology, Dyskinesia, Subclinical infection and Neuroscience.
Physical medicine and rehabilitation is closely connected to Transcranial magnetic stimulation in his research, which is encompassed under the umbrella topic of Subthalamic nucleus.
Between 2012 and 2021, his most popular works were:
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations. (131 citations)
- Two-Year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease (120 citations)
- Transcranial direct current stimulation of the affected hemisphere does not accelerate recovery of acute stroke patients. (114 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Stroke
His scientific interests lie mostly in Parkinson's disease, Internal medicine, Randomized controlled trial, Levodopa and Anesthesia.
Parkinson's disease is a subfield of Disease that Paolo Stanzione investigates.
His Internal medicine research is multidisciplinary, relying on both Endocrinology and Cardiology.
The concepts of his Randomized controlled trial study are interwoven with issues in Rating scale, Beck Depression Inventory, Clinical psychology, Rasagiline and Apathy.
His Levodopa study integrates concerns from other disciplines, such as Clinical endpoint, Dyskinesia, Audiology and Subclinical infection.
His study focuses on the intersection of Anesthesia and fields such as Physical medicine and rehabilitation with connections in the field of Stroke.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
